Thursday, October 02, 2025 10:32:31 AM
TSHA..........................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
Recent TSHA News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:09:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 12:30:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 12:11:42 PM
- Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/06/2026 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/01/2026 08:05:00 PM
- Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 • GlobeNewswire Inc. • 04/29/2026 12:00:00 PM
- Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting • GlobeNewswire Inc. • 04/27/2026 09:21:27 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:02:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:01:44 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/03/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 12:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:08:07 PM
- Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19 • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/06/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2026 09:07:56 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 09:07:49 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/06/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2026 11:44:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2026 11:42:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2026 11:41:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2026 11:39:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2026 01:04:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2026 01:02:44 AM
